Get the Stockscreener App
18.33
1.83%
0.33
Minimed Group Inc stock is traded at $18.33, with a volume of 1.31M.
It is up +1.83% in the last 24 hours and up +0.00% over the past month.
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.
See More
Previous Close:
$18.00
Open:
$18.03
24h Volume:
1.31M
Relative Volume:
26.62
Market Cap:
$5.15B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$17.98
$18.68
1-Week Range:
$17.94
$19.05
52-Week Range:
$17.94
$19.05
Minimed Group Inc Stock (MMED) Company Profile
Name
Minimed Group Inc
Sector
Industry
Phone
-
Address
-
Compare MMED vs VEEV, TEM, BTSG, HQY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MMED
Minimed Group Inc
|
18.33 | 5.05B | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
189.69 | 32.15B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
50.90 | 9.35B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.34 | 8.11B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
78.50 | 6.84B | 1.15B | 96.70M | -161.99M | 1.09 |
Minimed Group Inc Stock (MMED) Latest News
MiniMed expands sensor portfolio in Europe with CE Mark for MiniMed™ 780G system with the Instinct sensor, made by Abbott - PR Newswire
MiniMed Group Launches $560 Million Initial Public Offering Amid Separation from Medtronic - Global Legal Chronicle
MiniMed closes $560M IPO, Medtronic retains 90% stake - Investing.com
MiniMed closes IPO raising $538 million at $20 per share - Investing.com
MiniMed closes IPO raising $538 million at $20 per share By Investing.com - Investing.com Australia
MiniMed announces closing of Initial Public Offering - PR Newswire
MiniMed Debuts on Nasdaq as IPO Prophet Signals Align With Weak First-Day Trading - Smartkarma
Medtronic subsidiary MiniMed prices $560M IPO at $20 per share - MSN
U.S. IPO Weekly Recap: Diabetes Medtech MiniMed Slides 8% In A Quiet Week For IPOs - Seeking Alpha
MiniMed Group, Inc. (MMED): Medtronic Spinoff Falls on First Day Despite Deep IPO Discount - Smartkarma
MiniMed Group: Medtronic’s Diabetes Business Does Not Convince (NASDAQ:MMED) - Seeking Alpha
MiniMed, Integrated Diabetes Technology Provider, Files for NASDAQ $560M IPO - TradingView
Medtronic (MDT) Spins Off MiniMed (MMED) in $560M IPO on Nasdaq - MEXC
MiniMed (MMED) IPO Falls Flat as Medtronic (MDT) Spinoff Debuts Below Price - Blockonomi
MiniMed (MMED) IPO Stumbles as Medtronic (MDT) Completes $560M Diabetes Device Spinoff - MoneyCheck
Medtronic’s diabetes unit MiniMed drops on trading debut - Seeking Alpha
Medtronic's MiniMed falls in Nasdaq debut, fetches $5.35 billion in valuation - Reuters
Minimed IPO raises $560M as it splits from Medtronic - bioworld.com
MiniMed begins trading on Nasdaq under ticker MMED - Investing.com
Medtronic (MDT) Announces MiniMed Group IPO and Listing on Nasda - GuruFocus
MiniMed Group Begins Trading on Nasdaq Following IPO - Intellectia AI
MiniMed Rings the Opening Bell - Nasdaq
MiniMed begins trading on Nasdaq Global Select Market - PR Newswire
Medtronic subsidiary MiniMed prices $560M IPO at $20 per share (MMED:NASDAQ) - Seeking Alpha
MiniMed prices IPO at $20 per share, raising $560 million - Investing.com
Medtronic's diabetes unit MiniMed raises $560 million in US IPO - Reuters
Medtronic Unit Raises $560 Million in US IPO Priced Below Range - Bloomberg
MiniMed announces pricing of initial public offering - PR Newswire
Minimed Group, Inc To Start Trading Tomorrow - Benzinga
Medtronic Diabetes Unit MiniMed’s IPO Sparks Analyst Debate - Bloomberg
MiniMed Group, Inc. (MMED): Spin-Off IPO Story of Scale, Recurring Revenue, and Royalty Questions - Smartkarma
Should You Buy MMED Stock After the MiniMed IPO? - Barchart.com
MMED Ipo: MiniMed IPO Launch Date, Expected Pricing, And Valuation - EBC Financial Group
IPO Rating: MiniMed Group, Inc. - Smartkarma
The Great Unlocking: Medtronic’s Strategic Pivot and the MiniMed Spin-Off - FinancialContent
Medtronic’s diabetes unit MiniMed seeks up to $784M in US IPO - MSN
MiniMed Group, Inc. (MMED): Long-Awaited Medtronic Diabetes Spin-Off Sets Terms for IPO - Smartkarma
MMED Stock Price and Chart — NASDAQ:MMED - TradingView
Medtronic advances its innovation strategy with intent to acquire CathWorks - PR Newswire
MiniMed Group, Inc. (MMED): Peeking at the IPO Prospectus of Medtronic's Diabetes Spin-Off - Smartkarma
Medtronic discloses pay for Diabetes leaders ahead of MiniMed IPO - Medical Design & Outsourcing
Medtronic's MiniMed diabetes unit files for IPO as parent company prepares to spin off division - The Business Journals
Medtronic's Diabetes Unit MiniMed Files For US IPOMedline (NASDAQ:MDLN), Medtronic (NYSE:MDT) - Benzinga
Minimed Group, Inc. Appoints Ryan Weispfenning to Establish and Lead Investor Relations Function, Effective December 8, 2025 - marketscreener.com
FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes - Medtronic
Medtronic CEO Geoff Martha explains activist investor changes and offers updates on MiniMed and Hugo - Medical Design & Outsourcing
Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company - PR Newswire
Medtronic's $2.8B diabetes business spinoff will be called MiniMed - The Business Journals
Medtronic to spin out diabetes division as $2.8B independent player - Fierce Biotech
Investor lawsuit accuses Medtronic of failing to disclose insulin pump problems - MedTech Dive
Medtronic’s stock price falls nearly 9% following FDA warning letter - MedTech Dive
Minimed Group Inc Stock (MMED) Financials Data
There is no financial data for Minimed Group Inc (MMED). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
4.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):